High Sensitivity CRP Predicts Long-Term Mortality in Patients with Atrial Fibrillation and Evident Acute Coronary Syndrome
暂无分享,去创建一个
C. Hamm | Michael A Weber | C. Liebetrau | L. Gaede | H. Möllmann | J. Rixe | A. Rolf | A. Elsässer | H. Nef | S. Szardien | M. Willmer | O. Doerr | Matthias Willmer
[1] D. Brieger,et al. Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort. , 2013, International journal of cardiology.
[2] S. Plein,et al. Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance. , 2013, International journal of cardiology.
[3] K. Caidahl,et al. Effect of new versus known versus no atrial fibrillation on 30-day and 10-year mortality in patients with acute coronary syndrome. , 2012, The American journal of cardiology.
[4] K. Eagle,et al. Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation. , 2012, The Canadian journal of cardiology.
[5] M. Gawaz,et al. Macrophage Migration Inhibitory Factor Is Enhanced in Acute Coronary Syndromes and Is Associated with the Inflammatory Response , 2012, PloS one.
[6] K. Channon,et al. Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials , 2012, Current pharmaceutical design.
[7] R. Giugliano,et al. Can We Predict Outcomes in Atrial Fibrillation? , 2012, Clinical cardiology.
[8] C. Hamm,et al. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. , 2011, American heart journal.
[9] E. Benjamin,et al. Atrial fibrillation and death after myocardial infarction: risk marker or causal mediator? , 2011, Circulation.
[10] X. Jouven,et al. Atrial Fibrillation and Death After Myocardial Infarction: A Community Study , 2011, Circulation.
[11] Y. Jang,et al. Prognostic value of N-terminal probrain natriuretic peptide level on admission in patients with acute myocardial infarction and preserved left ventricular ejection fraction , 2011, Coronary artery disease.
[12] S. Pocock,et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. , 2010, Journal of the American College of Cardiology.
[13] E. Varol,et al. The association between previous statin use and development of atrial fibrillation in patients presenting with acute coronary syndrome. , 2010, International journal of cardiology.
[14] P. Sanders,et al. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. , 2009, The American journal of cardiology.
[15] S. Hohnloser,et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. , 2009, European heart journal.
[16] A. Peters,et al. Determinants of the acute-phase protein C-reactive protein in myocardial infarction survivors: the role of comorbidities and environmental factors. , 2009, Clinical chemistry.
[17] P. Cochat,et al. Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[18] Ohad Parnes,et al. Inflammation , 2008, The Lancet.
[19] L. Newby,et al. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation , 2008, Heart.
[20] J. Herlitz,et al. C‐reactive protein, interleukin‐6, secretory phospholipase A2 group IIA and intercellular adhesion molecule‐1 in the prediction of late outcome events after acute coronary syndromes , 2007, Journal of internal medicine.
[21] E. Adamopoulou,et al. The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes. , 2007, Atherosclerosis.
[22] G. Ramani,et al. Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome. , 2007, The American journal of cardiology.
[23] J. Struck,et al. C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial Infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study , 2007, Circulation.
[24] Silvia G. Priori,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .
[25] E. Watanabe,et al. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. , 2006, International journal of cardiology.
[26] E. Maltezos,et al. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. , 2006, The American journal of cardiology.
[27] B. Gersh,et al. Epidemiological profile of atrial fibrillation: a contemporary perspective. , 2005, Progress in cardiovascular diseases.
[28] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[29] C. Heeschen,et al. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. , 2005, Journal of the American College of Cardiology.
[30] K. Eagle,et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. , 2003, The American journal of cardiology.
[31] Y. Nishibori,et al. C‐Reactive Protein and Lesion Morphology in Patients With Acute Myocardial Infarction , 2003, Circulation.
[32] S. Marsch,et al. Inflammation and Long-Term Mortality After Non-ST Elevation Acute Coronary Syndrome Treated With a Very Early Invasive Strategy in 1042 Consecutive Patients , 2002, Circulation.
[33] Cynthia A. Carnes,et al. C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.
[34] A. Siegbahn,et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.
[35] K A Schulman,et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. , 2000, Circulation.
[36] A. Döring,et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.
[37] D. Levy,et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.
[38] F. Niculescu,et al. Inflammation, aspirin, and the risk of cardiovascular disease. , 1997, The New England journal of medicine.
[39] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[40] S. Thompson,et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.
[41] A S Kosinski,et al. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). , 1988, The American journal of cardiology.
[42] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[43] B. Astor,et al. Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study). , 2012, The American journal of cardiology.
[44] T. Henry,et al. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. , 2008, The American journal of cardiology.
[45] Satoshi Watanabe,et al. Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome. , 2008, The American journal of cardiology.